Revvity (RVTY) Net Income towards Common Stockholders Growth (3y) (2012 - 2026)
Powered by 
Analysis
Revvity (RVTY) Net Income towards Common Stockholders Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 8.89% |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | -7.69% |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 48.30% |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 42.35% |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 13.37% |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 6.14% |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 32.37% |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | -36.74% |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 34.02% |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | -45.83% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 5, 2026 | 13.37% |
| Apr 5, 2026 | -58.49% |
| Dec 28, 2025 | -24.44% |
| Sep 28, 2025 | -18.24% |
| Jun 29, 2025 | -32.98% |
| Mar 30, 2025 | -37.97% |
| Dec 29, 2024 | -32.36% |
| Sep 29, 2024 | -9.60% |
| Jun 30, 2024 | -38.61% |
| Mar 31, 2024 | -58.94% |
| Oct 1, 2023 | -62.26% |
| Jul 2, 2023 | -36.24% |
| Apr 2, 2023 | 156.70% |
| Jan 1, 2023 | 52.33% |
| Oct 2, 2022 | 13.38% |
| Jul 3, 2022 | 37.40% |
| Apr 3, 2022 | 70.97% |
| Jan 2, 2022 | 62.48% |
| Oct 3, 2021 | 18.61% |
| Jul 4, 2021 | 55.16% |